• No se han encontrado resultados

[PDF] Top 20 Poor response to hepatitis C treatment in elderly patients

PDF superior Poor response to hepatitis C treatment in elderly patients de 1Library.Co

Poor response to hepatitis C treatment in elderly patients

Poor response to hepatitis C treatment in elderly patients

... SVR in elderly patients, suggesting that baseline conditions are fundamental for the tolerance to and success of ...treatment. In older adults, the prevalence of changes ... See full document

7

Module VPredictive factors for response to treatment of chronic hepatitis C

Module VPredictive factors for response to treatment of chronic hepatitis C

... chronic hepatitis C Obesity reduces the efficacy of treatment with inter- ...chronic hepatitis C, increasing the necroinflammatory component and the grade of ...resistance to ... See full document

5

IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population

IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population

... the response to PEG-IFNa and RBV treatment in pa- tients infected with HCV-1 has been demonstrated ...extensively. Patients who carry the CC polymor- phism have SVR rates of > 80%, so ... See full document

6

Current concepts in the management and treatment of hepatitis C in HIV infected patients

Current concepts in the management and treatment of hepatitis C in HIV infected patients

... chronic hepatitis C, accelerating the pro- gression of liver ...lower response to anti-HCV therapy limits its benefit in the HIV/HCV-coinfected ...garding treatment monitoring, ... See full document

11

Racial Disparities in Hepatitis C Treatment Eligibility

Racial Disparities in Hepatitis C Treatment Eligibility

... than in most other HCV studies and, unlike prior studies, African American HCV patients constituted the majority (63%) rather than the minority of the ...used to identify individuals with recent ... See full document

8

Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients

Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients

... due to the small number of patients in the Latino and African American groups as compared to the Caucasian po- ...groups to obtain CHC treatment and their poor re- ... See full document

14

Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?

Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?

... coinfected patients is relatively ...analyzed in this study is one of the largest cohorts of hemodialy- sis coinfected patients evaluated so ...related to the baseline characteristics of ... See full document

8

TítuloReal life experience with direct acting antivirals agents against hepatitis C infection in elderly patients

TítuloReal life experience with direct acting antivirals agents against hepatitis C infection in elderly patients

... drugs to cause AE. In this cohort, when a PI is part of the regimen, AE were three times more frequent, independently of RBV ...due to AE [12]. Three patients who discontinued treatment ... See full document

8

E d i t o r i a l. Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C

E d i t o r i a l. Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C

... La infección crónica por el virus de la hepatitis C (VHC) afecta a un gran núme- ro de personas en todo el mundo y puede evolucionar a cirrosis hepática y hepato- carcinoma. En los países occidentales es la ... See full document

6

New approaches in the treatment of hepatitis C.

New approaches in the treatment of hepatitis C.

... antiviral treatment is to eradicate the ...only treatment strategy was based on the combination of pegylated interferon and ribavirin ...However, in genotypes 1 and 4 the rates of viral ... See full document

13

Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities  Two case reports

Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities Two case reports

... whether to treat the patient and any possible complications that may occur including wor- sening of the basic ...virological response (cEVR: not detectable HCV-RNA after 12 weeks of therapy), without ... See full document

5

Treatment issues surrounding hepatitis C in renal transplantation: A review

Treatment issues surrounding hepatitis C in renal transplantation: A review

... therapy in combination with ribavirin for the treat- ment of chronic hepatitis C in the non-transplant population, supported by robust phase 2, 3 and post- marketing clinical studies, there is ... See full document

10

Prevalence of hepatitis C virus genotypes in Mexican patients

Prevalence of hepatitis C virus genotypes in Mexican patients

... 1 to 6, as well as > 50 ...that treatment response varies accor- ding to ...was to ascer- tain prevalence of HCV genotypes in a group of patients from 10 states in ... See full document

5

Viral kinetics during the first month of treatment in patients with genotype 1 chronic hepatitis C

Viral kinetics during the first month of treatment in patients with genotype 1 chronic hepatitis C

... of response with the greatest statisti- cal significance were those associated with viral ...reduction in viremia ≥ 2 logs 2 weeks after treatment onset confirmed ...as patients could be ... See full document

9

New developments in the treatment of primary insomnia in elderly patients: focus on prolonged release melatonin

New developments in the treatment of primary insomnia in elderly patients: focus on prolonged release melatonin

... Most treatment guidelines recognize a symptom-free state as the best definition of remission of insomnia, in spite of the fact that functional recovery often lags behind symptomatic ...social) in ... See full document

14

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

... HCV-4 patients from Egypt who were eligi- ble for treatment with pegylated interferon α and ...All patients fulfilled the standards of care, inclusion and exclusion criteria for interferon thera- py, ... See full document

7

TítuloImpact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

TítuloImpact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

... 4-monoinfected patients showed significantly higher rates of SVR than those with HIV ...of patients with advanced liver damage was higher in HIV/HCV-coinfected patients, which could ... See full document

12

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

... whether in the future there will be a need for liver transplantation in patients with chronic HCV ...of patients who clear HCV with DAA-based regimens subsequently expe- rience improvement ... See full document

7

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C

... result in rib- avirin dose reduction or even discontinuation, which may significantly affect the overall sustained virologic re- sponse rates, especially in patients with HCV-genotype ...task ... See full document

8

Treatment of chronic hepatitis C virus infection in the near future

Treatment of chronic hepatitis C virus infection in the near future

... currently in late stages of ...use response guided therapy and will de- pend on a fixed regimen with a total duration of usually no more than 12 ...of patients tested is still small and few ... See full document

6

Show all 10000 documents...